Submission to the National Medicines Policy Consultation
Click here for Lung Foundation Australia’s response to the National Medicines Policy Consultation in 2021.
Submission to the Senate Inquiry on Tobacco Harm Reduction
Click here for Lung Foundation Australia’s submission to the Senate Inquiry on Tobacco Harm Reduction.
Comprehensive Genomic Profiling of Non-Small Cell Lung Cancer MSAC Submission
Click here for Lung Foundation Australia’s submission to MSAC to list comprehensive genomic profiling for non-small cell lung cancer tumour tissue specimens.
Alpha-1 Antitrypsin Genotyping MSAC Submission
Click here for Lung Foundation Australia’s submission to MSAC to list Alpha-1 Antitrypsin Genotyping on the Medicare Benefits Schedule.
Survey of Lung Foundation Australia Alpha1 Community
Click here to read results of a patient survey conducted into streamlining pathology testing for Alpha1 Antitrypsin.
Submission to the Senate Select Committee on COVID-19
Click here to access our submission to the federal government inquiry into the COVID-19 pandemic.
Submission: Lung Cancer Screening in Australia
Click here to learn more about what Lung Cancer Screening in Australia could look like.
National Strategic Action Plan for Lung Conditions: Occupational Dust Diseases
Click here for Lung Foundation Australia’s submission of the National Strategic Action plan for Occupational Dust diseases for the Dust Diseases Taskforce.
PBAC Consumer Comments DOS and DON’TS
Click here for the DOS and DONTS of writing consumer comments for PBAC submissions.
Tip sheet for submitting consumer comments to the PBAC
Click here for a tip sheet for submitting consumer comments to the Pharmaceutical Benefits Advisory Committee (PBAC).